Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1967 2
1968 4
1969 1
1970 1
1971 3
1972 2
1973 5
1974 2
1975 1
1976 2
1977 1
1978 6
1979 2
1981 3
1982 3
1983 1
1984 1
1985 2
1986 7
1987 6
1988 3
1989 1
1990 1
1991 5
1993 2
1994 1
1995 1
1996 1
1997 4
1998 2
1999 3
2000 3
2001 2
2002 8
2003 7
2004 7
2005 1
2006 4
2007 6
2008 13
2009 7
2010 7
2011 11
2012 6
2013 12
2014 5
2015 4
2016 9
2017 11
2018 4
2019 3
2020 4
2021 2
2022 2
2023 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
[Foix-Alajouanine syndrome, what is it?].
Shuleshova NV, Skoromets AA, Lu C, Zabrodskaia IuM, Sartakova-Korzhova AN, Nutfullina GM, Krasnov VS. Shuleshova NV, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(9):88-92. Zh Nevrol Psikhiatr Im S S Korsakova. 2014. PMID: 25403308 Review. Russian.
[Treatment of relapses of multiple sclerosis (a review)].
Brkovich RR, Totolian NA, Sokolov AIu, Ignatov IuD, Skoromets AA. Brkovich RR, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10 Pt 2):69-77. Zh Nevrol Psikhiatr Im S S Korsakova. 2013. PMID: 24416811 Review. Russian.
[Therapy of moderate cognitive impairment and asthenia in patients with cerebrovascular pathology: results of a prospective observational study].
Shvartsman GI, Skoromets AA, Zhivolupov SA, Kurushina OV, Karpov SM, Baranova NS, Nesterova MV, Smagina IV, Prokopenko SV, Antipenko EA, Novikova LB. Shvartsman GI, et al. Among authors: skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(8):88-94. doi: 10.17116/jnevro202212208188. Zh Nevrol Psikhiatr Im S S Korsakova. 2022. PMID: 36036408 Russian.
Telmisartan to prevent recurrent stroke and cardiovascular events.
Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Yusuf S, et al. N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27. N Engl J Med. 2008. PMID: 18753639 Free PMC article. Clinical Trial.
[The biomarkers of cerebral ischemia as a new method for the validation of the efficacy of cytoprotective therapy].
Dambinova SA, Aliev KT, Bondarenko EV, Ponomarev GV, Skoromets AA, Skoromets AP, Skoromets TA, Smolko DG, Shumilina MV. Dambinova SA, et al. Among authors: skoromets ap, skoromets aa. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):62-67. doi: 10.17116/jnevro20171175162-67. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28638033 Russian.
216 results